2 citations
,
November 2020 in “International Journal of Otorhinolaryngology and Head and Neck Surgery” The nasolabial flap is a reliable option for reconstructing oral defects in early cancer patients.
5 citations
,
March 2021 in “Hepatitis Monthly” Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.
49 citations
,
January 2003 in “Clinical and Experimental Dermatology” The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.
1 citations
,
August 2018 in “Journal of the American Academy of Dermatology” A young woman developed facial bumps before hair loss, which is unusual for her condition.
June 2026 in “Drug Delivery and Translational Research” The study presents a solid microneedle booster (SMB) as an advanced microneedling platform for treating androgenetic alopecia (AGA). The SMB integrates spring-driven perpendicular stamping with simultaneous liquid dosing, improving microchannel reproducibility and early transport. Tests on porcine skin revealed that SMB achieved greater microchannel surface coverage and deeper penetration than a roller. It also enhanced early-phase permeation, accelerating hair regrowth when combined with minoxidil (MXD) in vivo. Histological analysis showed increased follicle enrichment in the SMB + MXD group. SMB provides a one-step, directionality-controlled microneedling method that enhances early transport and promotes follicular maturation, with potential for broader dermatologic applications.
9 citations
,
October 2015 in “Cutaneous and ocular toxicology” Vemurafenib can cause scalp issues but can be managed without changing the dose.
Low-dose sorafenib can cause severe facial acne, treatable with topical medication.
July 2004 in “Hair transplant forum international” The document's conclusion cannot be provided because the document is not available for parsing.
March 2026 in “Journal of Investigative Dermatology” Folliculin slows hair growth, and blocking it might help treat hair loss.
61 citations
,
January 2019 in “American Journal of Clinical Dermatology” The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.
November 2025 in “Journal of Investigative Dermatology” 
September 2021 in “CRC Press eBooks” Acne keloidalis nuchae is a hair loss condition affecting men of African descent, causing scar-like bumps on the scalp and neck.
42 citations
,
September 2015 in “Gene” FGF5s can block the effects of FGF5, which may help control hair growth in cashmere goats.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” The herbal hair serum effectively supports hair growth, reduces hair fall, and improves shine.
May 2015 in “Journal of the American Academy of Dermatology” Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.
17 citations
,
January 2015 in “International Journal of Trichology” Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.
November 2023 in “International Journal of Pharmaceutics” The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.
1 citations
,
July 2016 in “PubMed” 5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.
5 citations
,
January 1991 in “Drugs of The Future” 1 citations
,
July 2025 in “Frontiers in Genetics” FilaggrinHigh melanomas have active FGFR signaling and weak GNA14 and Th1 signatures.
July 2025 in “bioRxiv (Cold Spring Harbor Laboratory)” A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.
1 citations
,
April 2021 in “Journal of The American Academy of Dermatology” Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.
August 2011 in “SpringerReference” 
July 2015 in “Journal of the Dermatology Nurses’ Association” A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.
February 2026 in “European Urology” Folicrex may help with hair growth and health but lacks clinical evidence.
5 citations
,
December 2021 in “Journal of Cosmetic Dermatology” QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.
February 2023 in “Archives of Dermatological Research” Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.
November 2025 in “Clinical Cosmetic and Investigational Dermatology” Tofacitinib is effective and safe for treating severe alopecia areata.
September 2022 in “Zenodo (CERN European Organization for Nuclear Research)”